P. Hautecoeur et al., VARIATIONS OF IL2, IL6, TNF-ALPHA PLASMATIC LEVELS IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Acta neurologica belgica, 97(4), 1997, pp. 240-243
We performed a longitudinal analysis of serum IL2, IL6 and TNF alpha c
oncentrations in 40 relapsing remitting MS patients and 20 healthy sub
jects. Disease activity was quantified by Minimal Record of Disease (M
. R. D.) for MS, every 2 or 3 months. IL2, IL6, TNF alpha production w
as analysed without and with PHA stimulation of whole blood for 2 hour
s at 37 degrees C. No significant change in IL2 level was found in MS
serum. Individual TNF alpha production was significantly increased (P
< 0.007) during relapses. The global spontaneous IL6 production was ma
rkedly higher in the relapse group than in the control group (p < 0.01
) and than in the remission group (P < 0.002) without significant indi
vidual variations of cytokine levels regarding the disease activity. P
roductions of cytokines were enhanced by PHA stimulation, a condition
that however suppressed the differences observed without mitogen stimu
lation. Our data suggest that TNF alpha could be a marker for relapses
while IL6 might reflect the global activity of the immune system in M
S.